8th retraction appears for researcher who faked patient records

An 8th paper has been retracted for Anna Ahimastos, a heart researcher who faked patient records. It’s the last in a chain of retractions that were the result of an investigation by her former workplace, Baker IDI Heart & Diabetes Institute in Australia. As with the others, she did not agree to the retraction. The investigation found fabricated patients records in … Continue reading 8th retraction appears for researcher who faked patient records

7th retraction for heart researcher who faked patient records

Anna Ahimastos, a heart researcher who faked patient records, has notched her 7th retraction. One more paper is expected to be retracted, according to a spokesperson from her former institution, the Baker IDI Heart & Diabetes Institute in Australia. As with the other retractions, the 2005 paper in Hypertension — about how the hypertension drug ramipril may help alleviate … Continue reading 7th retraction for heart researcher who faked patient records

NEJM pulls letter by heart researcher who faked patient records

A heart researcher who fabricated patient records has notched retraction number six — this time, for a letter in the New England Journal of Medicine. She has two more retractions forthcoming. The retraction comes at the request of Anna Ahimastos’s co-authors, following an investigation into her work by her former workplace, the Baker IDI Heart and Diabetes … Continue reading NEJM pulls letter by heart researcher who faked patient records

JAMA retracts second paper by heart researcher

A heart researcher who fabricated trial participants has notched a second JAMA retraction. The retraction comes at the request of her co-authors, after an investigation by her former employer wasn’t able to confirm that this study was valid. In September, we learned that Anna Ahimastos, who used to work at Baker IDI Heart and Diabetes Institute in Melbourne, Australia, … Continue reading JAMA retracts second paper by heart researcher

Heart researcher who faked patient data gets 4th retraction

A heart researcher who fabricated patient records for her studies on the blood pressure medication ramipril has earned her fourth retraction, and more are apparently on the way. For readers who are new to this case: Things first unraveled for Anna Ahimastos when a subanalysis of a JAMA clinical trial revealed “anomalies,” triggering an investigation. After Ahimastos admitted to … Continue reading Heart researcher who faked patient data gets 4th retraction

Heart researcher who faked patient data gets third retraction

A heart researcher has notched her third retraction, a small 2006 trial in Annals of Internal Medicine which seemed to show that a blood pressure drug could help people with artery disease walk further with less pain. Earlier this year, Anna Ahimastos, formerly a researcher at Baker IDI Heart and Diabetes Institute in Melbourne, lost a … Continue reading Heart researcher who faked patient data gets third retraction

“Fabricated results” retract JAMA clinical trial, plus a sub-analysis of the data

A JAMA clinical trial that suggested a blood pressure drug could help patients increase their physical fitness, and a sub-analysis of those data, have been retracted after “an admission of fabricated results” by the first author on both papers. The three-year clinical trial was published in JAMA in 2013.  It was retracted this morning. The trial found … Continue reading “Fabricated results” retract JAMA clinical trial, plus a sub-analysis of the data